Brevan Howard Capital Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,573
Closed -$344K 1359
2024
Q3
$344K Sell
20,573
-1,248
-6% -$26.8K ﹤0.01% 800
2024
Q2
$450K Buy
+21,821
New +$472K ﹤0.01% 648

Other funds holding PRTA

Brevan Howard Capital Management's PRTA Position: Q4 2024 in Review

Brevan Howard Capital Management sold out of Prothena Corp (PRTA) in Q4 2024, closing a stake of 20,573 shares — an estimated $344K sold.

Brevan Howard Capital Management first reported a position in PRTA in Q2 2024 and held it in 2 quarters. The position peaked at $450K in Q2 2024. 170 funds tracked by Wall St. Rank hold PRTA as of Q4 2024.

  • Brevan Howard Capital Management reported no remaining Prothena Corp position as of Q4 2024 after selling out during the quarter.
  • Brevan Howard Capital Management sold 20,573 Prothena Corp shares in Q4 2024, an estimated $344K.
  • Brevan Howard Capital Management first reported a position in Prothena Corp in Q2 2024 and held it in 2 quarters.
  • Brevan Howard Capital Management's Prothena Corp position peaked at $450K in Q2 2024.
  • 170 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2024.

Based on Brevan Howard Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.